MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report)’s stock price rose 3.3% during trading on Wednesday . The stock traded as high as $1.28 and last traded at $1.25. Approximately 16,024 shares traded hands during trading, a decline of 88% from the average daily volume of 134,123 shares. The stock had previously closed at $1.21.
MyMD Pharmaceuticals Stock Down 1.6 %
The business has a fifty day moving average price of $1.76 and a 200 day moving average price of $2.17.
MyMD Pharmaceuticals Company Profile
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Further Reading
- Five stocks we like better than MyMD Pharmaceuticals
- Why Are These Companies Considered Blue Chips?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How to Calculate Options Profits
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
